Dental Care Clinics in Interlochen, MI Accepting Medicare
3 Dental Care Clinics found. Showing 1 - 3
 Debra E Lewis Dds, Pc Dentist Medicare: Not Enrolled in Medicare Practice Location: 2120 M137, Interlochen, MI 49643 Phone: 231-276-6789 Fax: 231-276-7754 |
Larry Wareck Dentist Medicare: Not Enrolled in Medicare Practice Location: 2120 M 137 # 95, Interlochen, MI 49643 Phone: 231-276-9051 |
Trevor Kay Dds Pllc Clinic/Center - Dental Medicare: Not Enrolled in Medicare Practice Location: 2120 M 137, Interlochen, MI 49643 Phone: 231-276-9051 |
News Archive
New nimodipine oral solution receives FDA approval for subarachnoid hemorrhage treatment
On May 10, the U.S. Food and Drug Administration approved Nymalize, a new nimodipine oral solution, to treat patients experiencing symptoms resulting from ruptured blood vessels in the brain (subarachnoid hemorrhage).
Ornim receives FDA 510(k) clearance for non-invasive monitoring of blood flow in tissue
Ornim, Inc. is pleased to announce the receipt of 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market the CerOx 3210F monitor. Additionally to its previous clearance for non-invasive monitoring of regional hemoglobin oxygen saturation in the brain or skeletal muscle, the CerOx 3210F is now also intended for use as a non-invasive monitor of blood flow in tissue of adults.
Older people who engage in moderate to intense exercise less likely to have silent strokes
Older people who regularly exercise at a moderate to intense level may be less likely to develop the small brain lesions, sometimes referred to as "silent strokes," that are the first sign of cerebrovascular disease, according to a new study published in the June 8, 2011, online issue of Neurology, the medical journal of the American Academy of Neurology.
Male lumpectomy - first line treatment for prostate cancer
The so-called "male lumpectomy" - a minimally invasive interventional radiology treatment for prostate cancer - is as effective as surgery in destroying diseased tumors and can be considered a first-line treatment for patients of all risk levels and particularly those who have failed radiation, according to studies released at the Society of Interventional Radiology's 34th Annual Scientific Meeting.
› Verified 6 days ago